PPD Development LP
PPD, a Thermo Fisher Scientific company, is a global provider of clinical research solutions, including drug development, clinical trial management, laboratory services, and innovative technologies. With over three decades of experience and a vast network of sites worldwide, PPD is committed to accelerating drug development, improving trial efficiency, and delivering high-quality data to support regulatory success and patient access. The company emphasizes therapeutic expertise across multiple areas, adaptive trial designs, digital and decentralized solutions, and strategic partnerships to help clients bring treatments to market faster and more effectively.
Industries
Nr. of Employees
Very Large (1000+)
PPD Development LP
Wilmington, North Carolina, United States, North America
Products
GMP Laboratory Services
Provides analytical services for small molecules and biologics, including testing for APIs, drug products, and medical devices across all phases of drug development.
Preclarus Lab Solutions
Offers a suite of tools for data integration and management to enhance clinical trial performance and regulatory success.
Regulatory Affairs Solutions
Provides end-to-end regulatory services to navigate global regulatory environments and accelerate product approval.
Decentralized Clinical Trials (DCT)
Facilitates clinical trials using telemedicine and remote monitoring to improve recruitment and retention while ensuring data quality.
Accelerated Enrollment Solutions (AES)
Offers a network of global sites and patient data to streamline clinical trial recruitment and reduce timelines.
Integrated Clinical Development Consulting
Offers strategic consulting services across clinical development, regulatory strategy, and trial design to optimize drug development.
GMP Laboratory Services
Provides analytical services for small molecules and biologics, including testing for APIs, drug products, and medical devices across all phases of drug development.
Preclarus Lab Solutions
Offers a suite of tools for data integration and management to enhance clinical trial performance and regulatory success.
Regulatory Affairs Solutions
Provides end-to-end regulatory services to navigate global regulatory environments and accelerate product approval.
Decentralized Clinical Trials (DCT)
Facilitates clinical trials using telemedicine and remote monitoring to improve recruitment and retention while ensuring data quality.
Accelerated Enrollment Solutions (AES)
Offers a network of global sites and patient data to streamline clinical trial recruitment and reduce timelines.
Integrated Clinical Development Consulting
Offers strategic consulting services across clinical development, regulatory strategy, and trial design to optimize drug development.
Services
Full-service clinical development (CRO)
Comprehensive clinical development services spanning protocol design, site management, monitoring, biostatistics, pharmacovigilance and regulatory support across Phase I–IV.
Early development and adaptive trial design
Consultative services for early-phase programs including adaptive protocol development, statistical planning and access to early-phase operational capabilities.
Decentralized clinical trial solutions
Deployment of decentralized and hybrid trial elements including remote assessments, telemedicine visits, wearable data capture and patient-facing digital tools.
Targeted patient recruitment and engagement
Targeted recruitment campaigns, community- and digital-based outreach, site feasibility assessments and real-time monitoring to accelerate enrollment and diversify trial populations.
Bioanalytical and biomarker laboratory services
Laboratory testing services including bioanalytical methods, biomarker assay development, central lab testing and vaccine-specific assays to support clinical programs.
Integrated CRO + CDMO clinical supply and CMC support
Connected clinical supply chain and manufacturing services including CMC consulting, scale-up support, packaging/labeling and supply logistics to streamline development-to-supply handoffs.
Full-service clinical development (CRO)
Comprehensive clinical development services spanning protocol design, site management, monitoring, biostatistics, pharmacovigilance and regulatory support across Phase I–IV.
Early development and adaptive trial design
Consultative services for early-phase programs including adaptive protocol development, statistical planning and access to early-phase operational capabilities.
Decentralized clinical trial solutions
Deployment of decentralized and hybrid trial elements including remote assessments, telemedicine visits, wearable data capture and patient-facing digital tools.
Targeted patient recruitment and engagement
Targeted recruitment campaigns, community- and digital-based outreach, site feasibility assessments and real-time monitoring to accelerate enrollment and diversify trial populations.
Bioanalytical and biomarker laboratory services
Laboratory testing services including bioanalytical methods, biomarker assay development, central lab testing and vaccine-specific assays to support clinical programs.
Integrated CRO + CDMO clinical supply and CMC support
Connected clinical supply chain and manufacturing services including CMC consulting, scale-up support, packaging/labeling and supply logistics to streamline development-to-supply handoffs.
Expertise Areas
- Clinical trial management (Phase I–IV)
- Early-phase and adaptive trial design
- Decentralized and hybrid clinical trials
- Clinical data management and integration
Key Technologies
- Polymerase chain reaction (PCR)
- Electronic data capture (EDC) and eSource
- ePRO / eCOA platforms
- AI / machine learning for trial analytics